Public service: Rahman says IBVs business efforts will help the country with medical security.
Company eyeing growth prospects in the region amidst international tie-ups
NOT many in the pharmaceutical industry are looking at biosimilar medicine, but it is an area that Inno Bio Ventures Sdn Bhd (IBV) chairman Tan Sri Abdul Rahman Mamat intends to build the company on.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
